Zengwei Tang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 21

Top Topics

Cell Proliferation

Peritoneal Dialysis

Long Non Coding Rna

Top Venues

Clinical epigenetics

Proceedings of the National Academy of Sciences of the United States of America

Blood cancer journal

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zengwei Tang, Yuan Yang, Qi Zhang, Tingbo Liang
Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients. Clinical epigenetics 15 (1) (2023)
Zengwei Tang, Yuan Yang, Qi Zhang, Tingbo Liang
Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients. Clinical epigenetics 15 (1) (2023)
Yuan Yang, Zengwei Tang, Yuzhou Huang, Qinglin Hu, Shuqing Wang, Jiang Ji, Yali Du, Chen Yang, Miao Chen, Shimin Hu, Bing Han
Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study. Blood cancer journal 13 (1) (2023)
Yuan Yang, Zengwei Tang, Yuzhou Huang, Qinglin Hu, Shuqing Wang, Jiang Ji, Yali Du, Chen Yang, Miao Chen, Shimin Hu, Bing Han
Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study. Blood cancer journal 13 (1) (2023)
Zengwei Tang, Yuan Yang, Qi Zhang, Tingbo Liang
Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients. Clinical epigenetics 15 (1) (2023)
Zengwei Tang, Yuan Yang, Qi Zhang, Tingbo Liang
Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients. Clinical epigenetics 15 (1) (2023)
Zengwei Tang, Yuan Yang, Qi Zhang, Tingbo Liang
Correction: Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients. Clinical epigenetics 15 (1) (2023)
Zengwei Tang, Yuan Yang, Qi Zhang, Tingbo Liang
Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients. Clinical epigenetics 15 (1) (2023)
Yuan Yang, Zengwei Tang, Yuzhou Huang, Qinglin Hu, Shuqing Wang, Jiang Ji, Yali Du, Chen Yang, Miao Chen, Shimin Hu, Bing Han
Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study. Blood cancer journal 13 (1) (2023)
Zengwei Tang, Yuan Yang, Qi Zhang, Tingbo Liang
Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients. Clinical epigenetics 15 (1) (2023)
Zengwei Tang, Yuan Yang, Qi Zhang, Tingbo Liang
Correction: Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients. Clinical epigenetics 15 (1) (2023)
Zengwei Tang, Yuan Yang, Qi Zhang, Tingbo Liang
Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients. Clinical epigenetics 15 (1) (2023)
Zengwei Tang, Yuan Yang, Qi Zhang, Tingbo Liang
Correction: Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients. Clinical epigenetics 15 (1) (2023)
Wen Chen, Liang Wen, Yingying Bao, Zengwei Tang, Jianhui Zhao, Xiaozhen Zhang, Tao Wei, Jian Zhang, Tao Ma, Qi Zhang, Xiao Zhi, Jin Li, Cheng Zhang, Lei Ni, Muchun Li, Jianpeng Sheng
Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2. Proceedings of the National Academy of Sciences of the United States of America 119 (52) (2022)
Wen Chen, Liang Wen, Yingying Bao, Zengwei Tang, Jianhui Zhao, Xiaozhen Zhang, Tao Wei, Jian Zhang, Tao Ma, Qi Zhang, Xiao Zhi, Jin Li, Cheng Zhang, Lei Ni, Muchun Li, Jianpeng Sheng
Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2. Proceedings of the National Academy of Sciences of the United States of America 119 (52) (2022)
Zengwei Tang, Yuan Yang, Wen Chen, Enliang Li, Jianpeng Sheng
Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients. Journal of translational medicine 20 (1) (2022)
Wen Chen, Liang Wen, Yingying Bao, Zengwei Tang, Jianhui Zhao, Xiaozhen Zhang, Tao Wei, Jian Zhang, Tao Ma, Qi Zhang, Xiao Zhi, Jin Li, Cheng Zhang, Lei Ni, Muchun Li, Jianpeng Sheng
Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2. Proceedings of the National Academy of Sciences of the United States of America 119 (52) (2022)
Zengwei Tang, Yuan Yang, Wen Chen, Enliang Li, Jianpeng Sheng
Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients. Journal of translational medicine 20 (1) (2022)
Zengwei Tang, Yuan Yang, Wen Chen, Enliang Li, Jianpeng Sheng
Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients. Journal of translational medicine 20 (1) (2022)
Wen Chen, Liang Wen, Yingying Bao, Zengwei Tang, Jianhui Zhao, Xiaozhen Zhang, Tao Wei, Jian Zhang, Tao Ma, Qi Zhang, Xiao Zhi, Jin Li, Cheng Zhang, Lei Ni, Muchun Li, Jianpeng Sheng
Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2. Proceedings of the National Academy of Sciences of the United States of America 119 (52) (2022)
Wen Chen, Liang Wen, Yingying Bao, Zengwei Tang, Jianhui Zhao, Xiaozhen Zhang, Tao Wei, Jian Zhang, Tao Ma, Qi Zhang, Xiao Zhi, Jin Li, Cheng Zhang, Lei Ni, Muchun Li, Jianpeng Sheng
Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2. Proceedings of the National Academy of Sciences of the United States of America 119 (52) (2022)